Publication | Open Access
Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial
166
Citations
19
References
2008
Year
IC prolongs survival in ED SCLC with slightly better scores for QOL.
| Year | Citations | |
|---|---|---|
Page 1
Page 1